November 4, 2022
Ibudilast has a significant beneficial effect on slowly evolving lesions (SELs) in patients with progressive multiple sclerosis (MS), new data suggest. Through its effect on SELs, […]
November 3, 2022
Young adults who are moderate to heavy drinkers are at increased risk of suffering a stroke — and the risk goes up with more years of […]
November 3, 2022
New research confirms the importance of COVID-19 mRNA booster doses for patients with multiple sclerosis (MS) who are receiving the anti-CD20 monoclonal antibody ocrelizumab (Ocrevus), as […]
November 3, 2022
The US Centers for Disease Control and Prevention (CDC) has released updated and expanded recommendations for prescribing opioids for adults with acute and chronic pain not […]
November 2, 2022
Exposure to a traffic-related air pollutant significantly increases risk for dementia, new research suggests. Results from a meta-analysis, which included a total of more than 90 […]
November 2, 2022
Neurofilament light chain (NfL) is a biomarker for both disease progression and treatment response in multiple sclerosis (MS), but the search continues for additional biomarkers to […]
November 2, 2022
Two of the largest U.S. pharmacy chains, CVS Health and Walgreen Co., announced agreements in principle Wednesday to pay about $5 billion each to settle lawsuits […]
November 1, 2022
Dementia and mild cognitive impairment (MCI) disproportionately affect Black and Hispanic individuals, as well as people with less education, based on new U.S. data from The […]
October 31, 2022
Neurofilament light chain (NfL) is a well-known and useful biomarker for multiple sclerosis (MS) disease activity, but its association with disease progression is not well understood. […]